Back to Search Start Over

Conversion surgery for recurrent hepatic angiosarcoma after systemic chemotherapy with paclitaxel.

Authors :
Ushida, Yuta
Sato, Takafumi
Kato, Tomotaka
Shigematsu, Yasuyuki
Ito, Hiromichi
Suzuki, Takeshi
Inoue, Yosuke
Ono, Yoshihiro
Oba, Atsushi
Takahashi, Yu
Source :
Clinical Journal of Gastroenterology; Apr2022, Vol. 15 Issue 2, p427-432, 6p
Publication Year :
2022

Abstract

A 67-year-old man presented with hemorrhagic shock due to the rupture of hepatic tumor and underwent emergency partial resection of the right liver. Pathological examination revealed hepatic angiosarcoma with involvement in its surgical margin. Six months after the operation, disease recurrence was detected, and he was referred to our hospital for second opinion. CT revealed tumors at the liver cut surface and left lateral segment. The tumor at the liver cut surface abutted to the common bile duct and the portal vein. The tumor was deemed unresectable, and systemic chemotherapy with 4 courses of weekly paclitaxel was given with excellent response. Then, we performed partial liver resection of S4 and S1 with remnant right liver and middle hepatic vein, and wedge resection for the metastatic lesion of segment 3 as a conversion surgery. He developed a grade B bile leakage postoperatively and was discharged on postoperative day 28. He remained disease free for 8 months after the operation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18657257
Volume :
15
Issue :
2
Database :
Complementary Index
Journal :
Clinical Journal of Gastroenterology
Publication Type :
Academic Journal
Accession number :
155954569
Full Text :
https://doi.org/10.1007/s12328-021-01569-2